Antonio S. Montecalvo is Vice President, Health Policy of Organogenesis Holdings Inc.. Currently has a direct ownership of 168,268 shares of ORGO, which is worth approximately $536,774. The most recent transaction as insider was on Apr 01, 2024, when has been sold 1,752 shares (Class A Common Stock) at a price of $2.8 per share, resulting in proceeds of $4,905. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 168K
0% 3M change
22.9% 12M change
Total Value Held $536,774

Antonio S. Montecalvo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2024
SELL
Payment of exercise price or tax liability
$4,905 $2.8 p/Share
1,752 Reduced 1.03%
168,268 Class A Common Stock
Feb 21 2024
BUY
Grant, award, or other acquisition
-
43,732 Added 20.46%
170,020 Class A Common Stock
Feb 16 2024
SELL
Payment of exercise price or tax liability
$2,502 $3.48 p/Share
719 Reduced 0.57%
126,288 Class A Common Stock
Feb 15 2024
SELL
Payment of exercise price or tax liability
$36,465 $3.68 p/Share
9,909 Reduced 7.24%
127,007 Class A Common Stock
Apr 01 2023
SELL
Payment of exercise price or tax liability
$4,466 $2.13 p/Share
2,097 Reduced 1.51%
136,916 Class A Common Stock
Feb 22 2023
BUY
Grant, award, or other acquisition
-
99,428 Added 41.7%
139,013 Class A Common Stock
Feb 16 2023
SELL
Payment of exercise price or tax liability
$1,971 $2.75 p/Share
717 Reduced 1.78%
39,585 Class A Common Stock
Feb 15 2023
SELL
Payment of exercise price or tax liability
$3,647 $2.92 p/Share
1,249 Reduced 3.01%
40,302 Class A Common Stock
Apr 01 2022
SELL
Payment of exercise price or tax liability
$21,603 $7.89 p/Share
2,738 Reduced 6.18%
41,551 Class A Common Stock
Mar 10 2022
SELL
Open market or private sale
$817,488 $8.39 p/Share
97,436 Reduced 68.75%
44,289 Class A Common Stock
Mar 10 2022
BUY
Exercise of conversion of derivative security
$237,024 $3.46 p/Share
68,504 Added 32.59%
141,725 Class A Common Stock
Mar 09 2022
SELL
Open market or private sale
$85,200 $8.52 p/Share
10,000 Reduced 12.02%
73,221 Class A Common Stock
Feb 16 2022
SELL
Payment of exercise price or tax liability
$5,586 $7.78 p/Share
718 Reduced 0.86%
83,221 Class A Common Stock
Feb 15 2022
BUY
Grant, award, or other acquisition
-
14,383 Added 14.63%
83,939 Class A Common Stock
Apr 01 2021
SELL
Payment of exercise price or tax liability
$35,099 $19.83 p/Share
1,770 Reduced 2.48%
69,556 Class A Common Stock
Feb 16 2021
BUY
Grant, award, or other acquisition
-
8,260 Added 10.38%
71,326 Class A Common Stock
ASM

Antonio S. Montecalvo

Vice President, Health Policy
Canton, MA

Track Institutional and Insider Activities on ORGO

Follow Organogenesis Holdings Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORGO shares.

Notify only if

Insider Trading

Get notified when an Organogenesis Holdings Inc. insider buys or sells ORGO shares.

Notify only if

News

Receive news related to Organogenesis Holdings Inc.

Track Activities on ORGO